「proto」の検索結果

Drafts board-adopted charters establishing Audit and Compensation Committees for U.S. corporations, covering composition, independence, delegated powers, meeting protocol, reporting, and annual review. Adapts for public (SEC/SOX/exchange) or private governance regimes. Use when creating or refreshing committee charters, preparing for IPO governance readiness, onboarding directors, or conducting governance cleanup. Trigger keywords: audit committee charter, compensation committee charter, board governance, SOX compliance, Rule 10A-3, exchange-standard committees.

日本語の概要は準備中です。原文の説明を表示しています。

Operational decision frameworks: triage, escalation, case management, billing ops. Use for 'how to handle X cases', 'build triage', 'escalation protocol'.

日本語の概要は準備中です。原文の説明を表示しています。

Multi-pass structural code review with adversarial analysis, scope-aware dispatch, adversarial persona passes, and forced-finding protocol. Supports input modes: branch diff (default), PR number (#123), commit hash, pending changes (--pending). Use when asked to "review this PR", "code review", "pre-landing review", "check my diff", or "review #123". Proactively suggest when the user is about to merge or land code changes. NOT for behavioral verification against a running build (see mk:evaluate); NOT for post-implementation simplification (see mk:simplify).

日本語の概要は準備中です。原文の説明を表示しています。

Operational decision frameworks: triage, escalation, case management, billing ops. Use for 'how to handle X cases', 'build triage', 'escalation protocol'.

日本語の概要は準備中です。原文の説明を表示しています。

Target a specific Google Chrome user profile for browser automation via CDP. Discovers installed profiles from the Chrome Local State file, launches Chrome with the requested profile attached to a debug port, and connects agent-browser via `agent-browser connect <port>`. Use when "automate using my Work/Personal Chrome", "open site with my saved session", or "use Chrome profile named <name>". NOT for headless scraping without an existing user profile (use mk:agent-browser directly); NOT for importing cookies only (use agent-browser --auto-connect state save).

日本語の概要は準備中です。原文の説明を表示しています。

Manage Model Context Protocol (MCP) servers - discover, analyze, and execute tools/prompts/resources from configured MCP servers. Use when working with MCP integrations, need to discover available MCP capabilities, filter MCP tools for specific tasks, execute MCP tools programmatically, access MCP prompts/resources, or implement MCP client functionality. Supports intelligent tool selection, multi-server management, and context-efficient capability discovery.

日本語の概要は準備中です。原文の説明を表示しています。

Generate several distinct UI directions for a screen or flow before committing to one. Produces 2-4 named interface directions with layout logic, component choices, and tradeoffs, optionally with generated mockup images. Use when the user says "ideate the UI", "give me layout options", "design directions for this screen", "explore the interface", or after context/research and before prototyping. Part of the Product Design set.

日本語の概要は準備中です。原文の説明を表示しています。

Guide for creating high-quality MCP (Model Context Protocol) servers that enable LLMs to interact with external services through well-designed tools. Use when building MCP servers to integrate external APIs or services, whether in Python (FastMCP) or Node/TypeScript (MCP SDK).

日本語の概要は準備中です。原文の説明を表示しています。

Comprehensive reference for inter-process communication mechanisms -- every way processes can talk on a computer. Covers sockets (TCP, UDP, Unix domain), WebSockets, SSE, pipes (named/anonymous), shared memory (mmap, shm_open), message queues, signals, D-Bus, XPC (macOS), gRPC, REST, stdin/stdout, file-based coordination, and clipboard. Performance benchmarks, platform availability, and code examples for each. Special focus on which IPC works best for AI agent coordination. Activate on: "IPC", "inter-process communication", "process communication", "how do I talk between processes", "Unix socket vs TCP", "shared memory", "named pipe", "WebSocket vs SSE", "gRPC vs REST", "agent coordination IPC", "XPC service", "message passing", "stdout pipe", "D-Bus", "mmap". NOT for: distributed systems design (use distributed-systems), network protocol design (use networking), message queue infrastructure like Kafka (use data-pipeline-engineer).

日本語の概要は準備中です。原文の説明を表示しています。

Applies game theory to multi-agent coordination protocols with advisory claims, repeated interactions, daemon-mediated correlation, and deviation penalties. Use for Nash equilibrium checks, folk-theorem cooperation analysis, correlated-equilibrium routing, and price-of-anarchy audits in strategic agent systems. NOT for consumer pricing, card-game strategy, or general microeconomics outside agent coordination.

日本語の概要は準備中です。原文の説明を表示しています。

Expert in cluttering -- the lesser-known fluency disorder characterized by rapid/irregular speech rate, excessive disfluencies, and frequent ADHD comorbidity. Covers differential diagnosis from stuttering, assessment protocols, therapy approaches (rate control, self-monitoring, pragmatic awareness), technology-assisted intervention, and AI tools for people who clutter. Activate on 'cluttering', 'rapid speech disorder', 'speech rate too fast', 'speech disfluency not stuttering', 'disorganized speech', 'ADHD speech problems', 'cluttering vs stuttering', 'speech intelligibility', 'mazed speech', 'telescoping words'. NOT for stuttering-only treatment (overlap is common but they are distinct), hearing disorders, or voice disorders (pitch, resonance).

日本語の概要は準備中です。原文の説明を表示しています。

Meta-agent for creating new custom agents, skills, and MCP integrations. Expert in agent design, MCP development, skill architecture, and rapid prototyping. Activate on 'create agent', 'new skill', 'MCP server', 'custom tool', 'agent design'. NOT for using existing agents (invoke them directly), general coding (use language-specific skills), or infrastructure setup (use deployment-engineer).

日本語の概要は準備中です。原文の説明を表示しています。

Choose multi-agent architectures using environment-first analysis, coordination pressure, commitment tuning, and knowledge levels. Use for autonomy design, protocol choice, and coordination failures. NOT for single-agent planning, centralized schedulers, or prompt-only swarms.

日本語の概要は準備中です。原文の説明を表示しています。

AI-powered calendar management and agent-based scheduling coordination. Covers calendar APIs (Google Calendar, CalDAV/iCal), AI scheduling assistants (Reclaim, Clockwise, Motion, Cal.com), building custom calendar agents with MCP, multi-calendar merging, timezone management, focus block protection, meeting fatigue detection, and agent-to-agent meeting negotiation protocols. Activate on: "calendar agent", "AI scheduling", "calendar coordination", "meeting scheduling", "calendar API", "focus time protection", "calendar optimization", "Google Calendar MCP", "Reclaim", "Clockwise", "Motion", "Cal.com", "smart scheduling", "calendar-aware agent", "timezone scheduling", "agent negotiation meetings". NOT for: manual calendar UI component design (use form-validation-architect), project management scheduling or Gantt charts (use project-management-guru-adhd), general time-tracking or pomodoro apps (use adhd-daily-planner for time-awareness), building the agent itself from scratch (use agent-creator).

日本語の概要は準備中です。原文の説明を表示しています。

Performs alchemical free-energy calculations including relative binding free energy (RBFE / FEP+) and absolute binding free energy (ABFE) via OpenFE, FEP+, GROMACS, AMBER pmemd, and OpenMM with explicit lambda scheduling, soft-core potentials, MBAR/BAR analysis, cycle-closure validation, and protocol-appropriate enhanced sampling. Compares ML alternatives (Boltz-2 affinity, DeepDock). Use when ranking analogs by binding affinity beyond docking accuracy, performing prospective lead optimization, or validating SAR predictions.

日本語の概要は準備中です。原文の説明を表示しています。

Extracts cfDNA fragmentomics features (DELFI genome-wide short/long ratios, WPS nucleosome positioning, Griffin GC-corrected accessibility profiles, end-motifs/MDS, OCF) for cancer detection and tissue-of-origin from plasma WGS. Centers on the nuclease-footprint reframe (every feature re-reads one nucleosome object), the mandatory GC correction, and the cross-protocol non-comparability that breaks naive classifiers. Runs FinaleToolkit (real CLI/Python, MIT) and the Griffin Snakemake pipeline; DELFI is a method, not a package. Use when deriving fragment-based signal from cfDNA, choosing a feature family for detection vs subtyping, or diagnosing why a fragmentomic model failed validation.

日本語の概要は準備中です。原文の説明を表示しています。

Analyzes single-cell pooled CRISPR screens (Perturb-seq, CROP-seq, Perturb-CITE-seq, ECCITE-seq, multiome) where each cell carries an sgRNA and a scRNA-seq / surface-protein / chromatin readout. Covers experimental design (direct-capture Perturb-seq Dixit 2016 vs CROP-seq 3'UTR-barcoded Datlinger 2017 vs ECCITE-seq vs Multiome), MOI for sgRNA assignment, escaper-cell filtering (Mixscape, Papalexi 2021), SCEPTRE NB GLM + permutation for low-MOI (Barry 2024 Genome Biol 25:124), the Pertpy framework, factor decomposition, genome-scale Perturb-seq (Replogle 2022 Cell, 2.5M cells), and per-perturbation single-cell DE. Use when running a single-cell CRISPR screen, choosing direct-capture vs CROP-seq architecture, filtering escaper cells, performing single-cell DE, integrating Perturb-seq with pathway analysis, scaling to GW CRISPRi via Replogle protocol, or analyzing multi-omics screens.

日本語の概要は準備中です。原文の説明を表示しています。

Preprocess CLIP-seq reads (eCLIP, iCLIP, iCLIP2, iCLIP3, irCLIP, PAR-CLIP, FLASH) with protocol-specific UMI extraction, adapter trimming, length filtering, and post-alignment PCR-duplicate collapse. Use when raw CLIP FASTQ must be turned into deduplicated, crosslink-preserving BAM input for peak calling; choosing between two-pass and single-pass adapter trimming; deciding minimum read length; or mapping UMI patterns to specific eCLIP/iCLIP/iCLIP2/iCLIP3 library preps.

日本語の概要は準備中です。原文の説明を表示しています。

Computes sample size and power for clinical trials including continuous, binary, and time-to-event endpoints; superiority, non-inferiority, and equivalence designs; FDA 2016 non-inferiority margin selection with M1/M2 framework; Schoenfeld 1981 and Lakatos 1988 for survival; Schuirmann TOST and 80-125% bioequivalence; minimum clinically important difference (MCID) vs δ distinction. Use when justifying trial size in protocol or SAP per CONSORT 2025 item 16a.

日本語の概要は準備中です。原文の説明を表示しています。

Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.

日本語の概要は準備中です。原文の説明を表示しています。

End-to-end binder design using BindCraft hallucination. Use this skill when: (1) Designing protein binders with built-in AF2 validation, (2) Running production-quality binder campaigns, (3) Using different design protocols (fast, default, slow), (4) Need joint backbone and sequence optimization, (5) Want high experimental success rate. For backbone-only generation, use rfdiffusion. For QC thresholds, use protein-qc. For tool selection guidance, use binder-design.

日本語の概要は準備中です。原文の説明を表示しています。

Manage BAP (Bitcoin Attestation Protocol) identity files using bap-cli. This skill should be used when users need to create, decrypt, list, or extract BAP identity backups, work with .bep encrypted files, or generate test fixtures for Playwright tests involving BAP identities.

日本語の概要は準備中です。原文の説明を表示しています。

Plan, execute, and document validation, verification, and transfer of analytical procedures under the governing framework - ICH Q2(R2) and Q14, USP <1220>/<1225>/<1226>, ICH M10 bioanalytical, CLSI EP, or ISO/IEC 17025. Use for HPLC, LC-MS/MS, GC, CE, ICP-MS, dissolution, qNMR, qPCR, NIR, and ligand binding or cell-based assays whenever the question is whether a procedure is fit for its intended purpose. Triggers include "method validation", "analytical method validation", "AMV", "validation protocol", "acceptance criteria", "linearity", "reportable range", "accuracy and precision", "repeatability", "intermediate precision", "recovery", "LOD", "LOQ", "detection limit", "quantitation limit", "specificity", "robustness", "method transfer", "method comparison", "Deming", "Passing-Bablok", "Bland-Altman", "equivalence testing", "OOS investigation", "ICH Q2", "Q2(R2)", "Q14", "USP 1225", "ICH M10", "incurred sample reanalysis", "ISR", "CLSI EP", and any request to show that an assay works.

日本語の概要は準備中です。原文の説明を表示しています。

Determines unilateral vs bilateral aldosterone excess based on cortisol-corrected aldosterone ratios from adrenal venous sampling, with ratio >4:1 indicating unilateral excess, ratio 3:1 suggestive of bilateral hypersecretion, and interpretation dependent on cosyntropin stimulation protocol used during sampling. Use when analyzing AVS results to guide surgical vs medical treatment decisions; triggers include 'AVS lateralization ratio', 'cosyntropin-stimulated AVS', 'aldosterone-to-cortisol ratio >4:1', and 'ratio 3:1 suggestive of bilateral disease'.

日本語の概要は準備中です。原文の説明を表示しています。